Japanese Rxs allowing generics now 5.7%

12 February 2007

In Japan, only 5.7% of total prescriptions, which enable a physician to check in "an approval column" for generic substitution available, actually made the doctor change brand products to copy drugs, according to a survey to verify the impact on the medical fee revision for fiscal 2006, which was released at the last Chuikyo (the Central Social Insurance Medical Council) meeting.

The usage situation of generic drugs at 635 pharmacies among 1,000 health insurance pharmacies (response rate: 63.5%) was surveyed from October 1 through October 31, 2006, across the nation. "Signed" by a physician in the approved column accounted for 17.1% or 165,402 of 969,365 prescriptions in total. "No signature" in the column accounted for 82.9%, or 803,963.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight